Rademaker, Doortjevan der Wel, Anne W.T.van Eekelen, RikVoormolen, Daphne N.de Valk, Harold W.Evers, Inge M.Mol, Ben WillemFranx, ArieSiegelaar, Sarah E.van Rijn, Bas B.DeVries, J. HansPainter, Rebecca C.2023-11-232023-11-232023-12Rademaker, D, van der Wel, A W T, van Eekelen, R, Voormolen, D N, de Valk, H W, Evers, I M, Mol, B W, Franx, A, Siegelaar, S E, van Rijn, B B, DeVries, J H & Painter, R C 2023, 'Continuous glucose monitoring metrics and pregnancy outcomes in insulin-treated diabetes : A post-hoc analysis of the GlucoMOMS trial', Diabetes, Obesity and Metabolism, vol. 25, no. 12, pp. 3798-3806. https://doi.org/10.1111/dom.152761462-8902https://hdl.handle.net/2164/22265Funding Information: BWM is supported by a NHMRC investigatorgrant (GNT1176437) and BWM reports consultancy, travel support and research funding from Merck. All other authors declare no conflict of interest. The GlucoMOMS trial was funded by ZonMw, the Dutch Organisation for Health Research and Development, project number 80‐82310‐97‐11157. Continuous Glucose Monitors were purchased at a discount price at Medtronic®, Heerlen, The Netherlands. Neither ZonMw nor Medtronic had a role in study design, data collection, data analysis, data interpretation, or writing of the reports of either the original study or the current post hoc analysis. 109694446engSDG 3 - Good Health and Well-beingcontinuous glucose monitoringdiabetes in pregnancygestational diabeteslarge-for-gestational ageR Medicine (General)Internal MedicineEndocrinology, Diabetes and MetabolismEndocrinologyR1Journal article10.1111/dom.15276https://www.scopus.com/pages/publications/85171793407